Media Room

 

 

Latest News Releases
Apr 20, 2017

Nektar Therapeutics (Nasdaq: NKTR) today announced that it will host an analyst and investor event with clinical investigators on Saturday, June 3, 2017 at 6:00 pm CDT in Chicago, IL during the...

Apr 4, 2017

Nektar Therapeutics (Nasdaq: NKTR) today announced five preclinical data presentations for its immuno-oncology programs made at the American Association for Cancer Research (AACR) Annual Meeting...

Mar 27, 2017

Nektar Therapeutics (NASDAQ: NKTR) today announced that it has begun dosing in a Phase 1 clinical study evaluating NKTR-358, the company's new biologic therapy, which is being developed to treat a...

More »

Multimedia Libraries
Media Contacts
Dan Budwick
Pure Communications, Inc.
Media@purecommunications...

More »

Follow Us on LinkedIn
Follow Us on Twitter


print email
 
 
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide